Status
Conditions
Treatments
About
Observational, point of prevalence study determining the presence of anti-SARS-CoV-2 antibody
Full description
All Healthcare workers (HCW) who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance to contaminated areas were included. They were classified as asymptomatic and pauci-symptomatic. A COVID-19 IgG/IgM rapid test was used for antibody detection, and selected participants were subject to real time polymerase chain reaction (qPCR) for SARS-CoV-2.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
156 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal